<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-15T11:52:11Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/vk5mkm9tmk.1" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/vk5mkm9tmk.1</identifier>
                <datestamp>2026-05-13T15:31:42Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>Yang, Huidan</dc:creator>
    <dc:title>Supplementary Materials for: A novel stratification framework based on vascular-fibrotic complications identifies distinct risk endotypes in systemic sclerosis: a retrospective cohort study.</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>This dataset contains supplementary tables (Tables S1–S2) for the article entitled &quot;A novel stratification framework based on vascular-fibrotic complications identifies distinct risk endotypes in systemic sclerosis: a retrospective cohort study&quot;. Table S1 provides detailed comparative data on additional autoantibodies (including anti‑SSA, anti‑SSB, anti‑dsDNA, anti‑Sm, anti‑nRNP/Sm, anti‑nucleosome [ANuA], anti‑histone [AHA], and anti‑ribosomal P protein [anti‑Rib‑P]) across the four complication‑based subgroups (Vascular‑dominant, Fibrotic‑dominant, Mixed, and Limited). Table S2 presents echocardiographic parameters (left ventricular ejection fraction [LVEF], E/A ratio) and serum cardiac enzymes (creatine kinase [CK], CK‑MB, lactate dehydrogenase [LDH], hydroxybutyrate dehydrogenase [HBDH]) with available data. These supplementary materials support the findings reported in the main manuscript.</dc:description>
    <dc:subject>Dermatology</dc:subject>
    <dc:subject>Rheumatology</dc:subject>
    <dc:subject>Systemic Sclerosis</dc:subject>
    <dc:contributor>Cheng, Hao</dc:contributor>
    <dc:contributor>Li, Juanjuan</dc:contributor>
    <dc:contributor>Zhang, Mingyang</dc:contributor>
    <dc:contributor>Zhao, Qiong</dc:contributor>
    <dc:contributor>Wang, Kai</dc:contributor>
    <dc:contributor>Yan, Chenglan</dc:contributor>
    <dc:contributor>Wen, Hongyan</dc:contributor>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/vk5mkm9tmk.1</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/vk5mkm9tmk.1</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/vk5mkm9tmk</dc:relation>
    <dc:date>2026-05-13T15:31:42Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
